Utah’s Life Sciences Companies
-
BioHive Launched at Utah Life Sciences Summit – Join the Campaign
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the…
-
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific…
-
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
-
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
Governor Herbert Announces New COVID-19 Transmission Index
On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan…
-
SINTX Technologies Develops New Mask Fabric with Silicon Nitride
On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory…
-
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
-
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology
U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners…
-
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives
Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
-
Foldax Named Finalist in the Fierce Innovation Awards
Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020,…
-
Alucent Biomedical Announces $35 Million Series B Financing
Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is…
-
IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration
IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung…
-
SDP Oncology Announces New Data from Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase…
-
RenalytixAI Receives California Commercial Lab Certification
RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from…
-
The Point Kick Off
On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning…
-
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the…
-
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National…
-
BioFire Respiratory Panel with COVID Target Scores CE Mark
BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19…
-
PhotoPharmics Stay-At-Home Trial for People with Parkinson’s
This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of…
-
AdvaMed Request for Tariff Exclusions for Medical Technology Products
The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs…
-
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million…
-
BioUtah COVID-19 Life Sciences Survey
TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach…
-
Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco
March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
